The rearranged during transfection proto-oncogene (RET) and v-ros proto-oncogene (ROS1) have also been identified as fusion types that contribute to lung cancer by leading to constitutive activation of kinase (Davies and Doebele, 2013; Tsuta et al., 2014). Here, ROS1 is linked to lung cancer.